- Corporate Officers - B
- Bentsur Ron
Insider Trading History of Bentsur Ron
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bentsur Ron since 2006.
This trader's CIK number is 1251213.
At the time of last reporting, Bentsur Ron was the Chairman & CEO of Nuvectis Pharma, Inc.. (stock ticker symbol NVCT).
Also see all insider trading activities at Nuvectis Pharma, Inc..
Note that in the past
BENTSUR RON also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Nuvectis Pharma, Inc. (NVCT) by Bentsur Ron
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | NVCT | 28,940 | $175,724 | 0 | $0 | 0 | $0 |
| 2023 | NVCT | 12,025 | $154,956 | 0 | $0 | 0 | $0 |
| 2022 | NVCT | 329,000 | $1,998,895 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Keryx Biopharmaceuticals Inc (KERX) by Bentsur Ron
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | KERX | 0 | $0 | 207,166 | $2,917,459 | 0 | $0 |
| 2014 | KERX | 0 | $0 | 468,676 | $6,699,779 | 0 | $0 |
| 2013 | KERX | 0 | $0 | 43,981 | $288,849 | 0 | $0 |
| 2012 | KERX | 90,500 | $123,227 | 4,735 | $12,065 | 0 | $0 |
| 2011 | KERX | 7,500 | $22,912 | 28,791 | $137,620 | 0 | $0 |
| 2010 | KERX | 0 | $0 | 286,649 | $1,380,290 | 0 | $0 |
| 2009 | KERX | 85,560 | $34,758 | 0 | $0 | 0 | $0 |
| 2006 | KERX | 0 | $0 | 35,000 | $659,260 | 35,000 | $38,500 |
Yearly summary of insider trading at Stemline Therapeutics Inc (STML) by Bentsur Ron
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | STML | 0 | $0 | 1,388 | $22,374 | 5,421 | $22,171 |
Yearly summary of insider trading at Xtl Biopharmaceuticals Ltd (XTLB) by Bentsur Ron
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | XTLB | 15,279 | $19,862 | 0 | $0 | 0 | $0 |
| 2006 | XTLB | 1,600 | $4,768 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Beyond Air, Inc. (XAIR) by Bentsur Ron
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | XAIR | 2,300 | $14,904 | 0 | $0 | 0 | $0 |
| 2022 | XAIR | 0 | $0 | 40,000 | $261,119 | 0 | $0 |
| 2021 | XAIR | 0 | $0 | 68,083 | $705,755 | 73,419 | $282,530 |
| 2020 | XAIR | 0 | $0 | 92,283 | $539,616 | 0 | $0 |
| 2018 | XAIR | 0 | $0 | 0 | $0 | 23,419 | $99,530 |
Insider trading activities at 5 companies by Bentsur Ron:
1. Nuvectis Pharma, Inc. (NVCT)
2. Keryx Biopharmaceuticals Inc (KERX)
3. Stemline Therapeutics Inc (STML)
4. Xtl Biopharmaceuticals Ltd (XTLB)
5. Beyond Air, Inc. (XAIR)
Table 1. Insider trading of Nuvectis Pharma, Inc. (NVCT) by Bentsur Ron
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-11-15 | NVCT | Buy | 20,000 | 4.92 | 98,400 |
| 2024-05-14 | NVCT | Buy | 1,940 | 6.74 | 13,075 |
| 2024-05-10 | NVCT | Buy | 2,000 | 6.40 | 12,800 |
| 2024-03-18 | NVCT | Buy | 5,000 | 10.29 | 51,449 |
| 2023-10-10 | NVCT | Buy | 640 | 11.08 | 7,091 |
| 2023-10-06 | NVCT | Buy | 250 | 11.27 | 2,817 |
| 2023-10-09 | NVCT | Buy | 830 | 11.19 | 9,287 |
| 2023-10-05 | NVCT | Buy | 1,400 | 11.09 | 15,526 |
| 2023-10-04 | NVCT | Buy | 1,820 | 10.95 | 19,929 |
| 2023-08-15 | NVCT | Buy | 235 | 14.34 | 3,369 |
| 2023-08-16 | NVCT | Buy | 115 | 15.15 | 1,742 |
| 2023-08-08 | NVCT | Buy | 120 | 14.83 | 1,779 |
| 2023-08-11 | NVCT | Buy | 180 | 14.66 | 2,638 |
| 2023-07-21 | NVCT | Buy | 225 | 14.85 | 3,341 |
| 2023-07-20 | NVCT | Buy | 110 | 15.06 | 1,656 |
| 2023-07-19 | NVCT | Buy | 200 | 14.33 | 2,866 |
| 2023-07-14 | NVCT | Buy | 150 | 15.03 | 2,254 |
| 2023-07-07 | NVCT | Buy | 110 | 16.19 | 1,780 |
| 2023-07-06 | NVCT | Buy | 320 | 14.88 | 4,761 |
| 2023-06-26 | NVCT | Buy | 750 | 16.50 | 12,375 |
| 2023-06-21 | NVCT | Buy | 500 | 17.88 | 8,940 |
| 2023-06-08 | NVCT | Buy | 120 | 17.53 | 2,103 |
| 2023-06-07 | NVCT | Buy | 230 | 17.41 | 4,004 |
| 2023-05-31 | NVCT | Buy | 330 | 17.28 | 5,702 |
| 2023-05-24 | NVCT | Buy | 200 | 17.49 | 3,497 |
| 2023-05-16 | NVCT | Buy | 320 | 17.02 | 5,448 |
| 2023-03-23 | NVCT | Buy | 230 | 12.13 | 2,789 |
| 2023-03-21 | NVCT | Buy | 480 | 12.08 | 5,798 |
| 2023-03-14 | NVCT | Buy | 1,680 | 10.85 | 18,228 |
| 2023-03-15 | NVCT | Buy | 480 | 10.91 | 5,236 |
| 2022-11-30 | NVCT | Buy | 150 | 7.45 | 1,117 |
| 2022-11-25 | NVCT | Buy | 150 | 7.38 | 1,107 |
| 2022-11-29 | NVCT | Buy | 150 | 7.45 | 1,117 |
| 2022-11-28 | NVCT | Buy | 150 | 7.40 | 1,110 |
| 2022-11-17 | NVCT | Buy | 250 | 7.24 | 1,810 |
| 2022-11-18 | NVCT | Buy | 500 | 7.23 | 3,615 |
| 2022-09-28 | NVCT | Buy | 500 | 7.23 | 3,615 |
| 2022-09-30 | NVCT | Buy | 500 | 7.46 | 3,730 |
| 2022-09-23 | NVCT | Buy | 1,000 | 7.93 | 7,930 |
| 2022-09-26 | NVCT | Buy | 500 | 7.69 | 3,845 |
| 2022-09-02 | NVCT | Buy | 1,200 | 8.37 | 10,043 |
| 2022-09-01 | NVCT | Buy | 500 | 8.11 | 4,054 |
| 2022-08-23 | NVCT | Buy | 500 | 9.00 | 4,500 |
| 2022-08-29 | NVCT | Buy | 1,000 | 9.07 | 9,070 |
| 2022-08-18 | NVCT | Buy | 14,426 | 8.58 | 123,775 |
| 2022-08-19 | NVCT | Buy | 5,000 | 8.99 | 44,950 |
| 2022-08-11 | NVCT | Buy | 19,669 | 8.40 | 165,219 |
| 2022-06-28 | NVCT | Buy | 300 | 11.82 | 3,546 |
| 2022-06-29 | NVCT | Buy | 3,700 | 11.62 | 42,994 |
| 2022-06-22 | NVCT | Buy | 100 | 13.10 | 1,310 |
| 2022-06-23 | NVCT | Buy | 200 | 11.40 | 2,280 |
| 2022-06-24 | NVCT | Buy | 400 | 12.18 | 4,872 |
| 2022-05-26 | NVCT | Buy | 500 | 15.90 | 7,950 |
| 2022-05-27 | NVCT | Buy | 500 | 15.74 | 7,870 |
| 2022-05-19 | NVCT | Buy | 200 | 18.95 | 3,790 |
| 2022-05-20 | NVCT | Buy | 1,000 | 16.28 | 16,280 |
| 2022-05-18 | NVCT | Buy | 1,700 | 19.55 | 33,226 |
| 2022-05-17 | NVCT | Buy | 310 | 20.30 | 6,293 |
| 2022-05-13 | NVCT | Buy | 700 | 18.10 | 12,670 |
| 2022-05-16 | NVCT | Buy | 1,000 | 19.32 | 19,320 |
| 2022-05-12 | NVCT | Buy | 12,245 | 16.09 | 196,985 |
| 2022-03-28 | NVCT | Buy | 4,000 | 7.05 | 28,200 |
| 2022-03-17 | NVCT | Buy | 7,000 | 7.63 | 53,410 |
| 2022-02-14 | NVCT | Buy | 8,000 | 5.88 | 47,040 |
| 2022-02-10 | NVCT | Buy | 8,500 | 6.34 | 53,890 |
| 2022-02-07 | NVCT | Buy | 20,000 | 6.09 | 121,800 |
| 2022-02-04 | NVCT | Buy | 212,500 | 4.45 | 944,562 |
Table 2. Insider trading of Keryx Biopharmaceuticals Inc (KERX) by Bentsur Ron
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-04-06 | KERX | Sale | 1,592 | 11.68 | 18,594 |
| 2015-01-05 | KERX | Sale | 5,574 | 13.79 | 76,865 |
| 2014-12-30 | KERX | Sale | 200,000 | 14.11 | 2,822,000 |
| 2014-12-29 | KERX | Sale | 87,988 | 13.98 | 1,230,072 |
| 2014-12-26 | KERX | Sale | 63,500 | 13.98 | 887,730 |
| 2014-12-24 | KERX | Sale | 83,000 | 13.98 | 1,160,340 |
| 2014-12-23 | KERX | Sale | 104,489 | 13.98 | 1,460,756 |
| 2014-10-03 | KERX | Sale | 2,038 | 16.14 | 32,893 |
| 2014-10-06 | KERX | Sale | 68,800 | 15.87 | 1,091,856 |
| 2014-09-12 | KERX | Sale | 50,000 | 14.24 | 712,000 |
| 2014-07-07 | KERX | Sale | 1,788 | 15.75 | 28,161 |
| 2014-04-03 | KERX | Sale | 1,816 | 16.46 | 29,891 |
| 2014-01-03 | KERX | Sale | 5,257 | 12.57 | 66,080 |
| 2013-10-03 | KERX | Sale | 2,505 | 10.25 | 25,676 |
| 2013-07-05 | KERX | Sale | 2,440 | 7.95 | 19,398 |
| 2013-04-05 | KERX | Sale | 1,795 | 6.93 | 12,439 |
| 2013-03-27 | KERX | Sale | 31,231 | 6.88 | 214,869 |
| 2013-01-04 | KERX | Sale | 6,010 | 2.74 | 16,467 |
| 2012-10-03 | KERX | Sale | 746 | 2.72 | 2,029 |
| 2012-07-03 | KERX | Sale | 684 | 1.99 | 1,361 |
| 2012-04-18 | KERX | Buy | 19,100 | 1.29 | 24,696 |
| 2012-04-04 | KERX | Buy | 71,400 | 1.38 | 98,531 |
| 2012-01-03 | KERX | Sale | 3,305 | 2.62 | 8,675 |
| 2011-08-10 | KERX | Buy | 7,500 | 3.06 | 22,912 |
| 2011-03-24 | KERX | Sale | 28,791 | 4.78 | 137,620 |
| 2010-12-03 | KERX | Sale | 50,000 | 5.01 | 250,500 |
| 2010-12-02 | KERX | Sale | 205,560 | 5.05 | 1,038,078 |
| 2010-03-24 | KERX | Sale | 31,089 | 2.95 | 91,712 |
| 2009-06-23 | KERX | Buy | 5,560 | .90 | 4,998 |
| 2009-05-22 | KERX | Buy | 80,000 | .37 | 29,760 |
| 2006-03-29 | KERX | Option Ex | 35,000 | 1.10 | 38,500 |
| 2006-03-29 | KERX | Sale | 35,000 | 18.84 | 659,260 |
Table 3. Insider trading of Stemline Therapeutics Inc (STML) by Bentsur Ron
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-03-18 | STML | Option Ex | 5,421 | 4.09 | 22,171 |
| 2015-03-18 | STML | Sale | 1,388 | 16.12 | 22,374 |
Table 4. Insider trading of Xtl Biopharmaceuticals Ltd (XTLB) by Bentsur Ron
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-08-21 | XTLB | Buy | 15,279 | 1.30 | 19,862 |
| 2006-08-25 | XTLB | Buy | 1,600 | 2.98 | 4,768 |
Table 5. Insider trading of Beyond Air, Inc. (XAIR) by Bentsur Ron
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-03-20 | XAIR | Buy | 2,300 | 6.48 | 14,904 |
| 2022-06-30 | XAIR | Sale | 40,000 | 6.53 | 261,119 |
| 2021-11-24 | XAIR | Sale | 37,464 | 13.71 | 513,818 |
| 2021-11-22 | XAIR | Option Ex | 50,000 | 3.66 | 183,000 |
| 2021-02-12 | XAIR | Sale | 23,419 | 6.36 | 148,944 |
| 2021-02-11 | XAIR | Sale | 1,500 | 6.28 | 9,420 |
| 2021-02-12 | XAIR | Option Ex | 23,419 | 4.25 | 99,530 |
| 2021-01-02 | XAIR | Sale | 5,700 | 5.89 | 33,573 |
| 2020-08-24 | XAIR | Sale | 3,889 | 5.68 | 22,105 |
| 2020-08-21 | XAIR | Sale | 3,246 | 6.05 | 19,651 |
| 2020-08-19 | XAIR | Sale | 6,533 | 6.32 | 41,268 |
| 2020-08-20 | XAIR | Sale | 3,778 | 6.29 | 23,778 |
| 2020-08-18 | XAIR | Sale | 4,578 | 5.83 | 26,689 |
| 2020-08-17 | XAIR | Sale | 4,413 | 5.72 | 25,224 |
| 2020-08-14 | XAIR | Sale | 6,680 | 5.53 | 36,933 |
| 2020-08-13 | XAIR | Sale | 4,088 | 5.50 | 22,496 |
| 2020-08-12 | XAIR | Sale | 4,689 | 5.30 | 24,832 |
| 2020-07-27 | XAIR | Sale | 4,917 | 6.26 | 30,805 |
| 2020-08-11 | XAIR | Sale | 3,910 | 5.51 | 21,551 |
| 2020-08-10 | XAIR | Sale | 3,437 | 5.42 | 18,635 |
| 2020-08-07 | XAIR | Sale | 10,222 | 5.35 | 54,657 |
| 2020-08-05 | XAIR | Sale | 3,619 | 6.16 | 22,285 |
| 2020-08-06 | XAIR | Sale | 6,192 | 5.94 | 36,780 |
| 2020-08-04 | XAIR | Sale | 3,649 | 6.13 | 22,368 |
| 2020-08-03 | XAIR | Sale | 3,814 | 6.16 | 23,490 |
| 2020-07-31 | XAIR | Sale | 2,868 | 6.27 | 17,970 |
| 2020-07-29 | XAIR | Sale | 4,343 | 6.15 | 26,696 |
| 2020-07-30 | XAIR | Sale | 3,418 | 6.26 | 21,403 |
| 2018-02-16 | AITB | Option Ex | 23,419 | 4.25 | 99,530 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bentsur Ron
(Chairman & CEO of Nuvectis Pharma, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.